ALZN stock news
This page provides real-time market news, earnings updates, and company announcements related to Alzamend Neuro, Inc. (ALZN).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-04-18 02:09 EST
Alzamend Neuro Reports Positive Topline Data from Phase II Clinical Trial of AL001 "Lithium in Brain" Study; AL001 Achieves Bioequivalence and Demonstrates Superior Brain Delivery Across All Measured Brain Regions
Finviz2026-03-26 12:03:47
Alzamend Neuro Reports Encouraging Pharmacodynamic Data from Phase II Clinical Trial of AL001 "Lithium in Brain" Study in a Trial Conducted at Massachusetts General Hospital
Finviz2026-04-07 12:03:48
ALZN stock chart
ALZN stock detailsALZN stock price change
On the last trading day, ALZN stock closed at 1.11 USD, with a price change of 11.00% for the day.
Trade stock perpsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more